SCHEMBL8046391

SCHEMBL8046391

Cn1nc(C(C)(C)C)c2nc(N(Cc3ccnc(N4CCOCC4)c3)CC3CCCCC3)[nH]c(=O)c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
OPRM1 P35372 1/20 0.33
OPRL1 P41146 1/20 0.33
POLB P06746 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
HIF1A Q16665 1/20 0.32
MCOLN3 Q8TDD5 1/20 0.32
ATM Q13315 8/20 0.32
PIK3C3 Q8NEB9 1/20 0.32
MAPK14 Q16539 1/20 0.32
HCRTR1 O43613 1/20 0.31
HCRTR2 O43614 1/20 0.31
ATR Q13535 2/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4128842 0.88 KDM4E (0.35) KDM4ENPSR1ALDH1A1MAPTSMN1; SMN2
SCHEMBL4117755 0.80 KDM4E (0.41) KDM4ENPSR1ALDH1A1MAPTSMN1; SMN2
SCHEMBL4133677 0.79 TPH1 (0.33) KDM4EALDH1A1MAPTHTTATM
SCHEMBL4123024 0.78 ALDH1A1 (0.36) KDM4ENPSR1ALDH1A1MAPTSMN1; SMN2
SCHEMBL8045132 0.78 KDM4E (0.41) KDM4ENPSR1ALDH1A1MAPTSMN1; SMN2
SCHEMBL4131082 0.76 MAPT (0.34) KDM4ENPSR1ALDH1A1MAPTSMN1; SMN2
SCHEMBL8032546 0.75 HCRTR1 (0.37) KDM4ENPSR1ALDH1A1MAPTSMN1; SMN2
SCHEMBL8034133 0.75 KDM4E (0.36) KDM4ENPSR1ALDH1A1MAPTSMN1; SMN2
SCHEMBL3995952 0.75 KDM4E (0.39) KDM4ENPSR1ALDH1A1MAPTSMN1; SMN2
SCHEMBL4128912 0.74 PDE5A (0.41) ALDH1A1PDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed